The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
Open accessAbstract
BACKGROUND AND PURPOSE Oxidative stress [i.e. increased levels of reactive oxygen species (ROS)] has been suggested as a pathomechanism of different diseases, although the disease‐relevant sources of ROS remain to be identified. One of these sources may be NADPH oxidases. However, due to increasing concerns about the specificity of the compounds commonly used as NADPH oxidase inhibitors, data obtained with these compounds may have to be re‐interpreted. EXPERIMENTAL APPROACH We compared the pharmacological profiles of the commonly used NADPH oxidase inhibitors, diphenylene iodonium (DPI), apocynin and 4‐(2‐amino‐ethyl)‐benzolsulphonyl‐fluoride (AEBSF), as well as the novel triazolo pyrimidine VAS3947. We used several assays for detecting cellular and tissue ROS, as none of them is specific and artefact free. KEY RESULTS DPI abolished NADPH oxidase‐mediated ROS formation, but also inhibited other flavo‐enzymes such as NO synthase (NOS) and xanthine oxidase (XOD). Apocynin interfered with ROS detection and varied considerably in efficacy and potency, as did AEBSF. Conversely, the novel NADPH oxidase inhibitor, VAS3947, consistently inhibited NADPH oxidase activity in low micromolar concentrations, and interfered neither with ROS detection nor with XOD or eNOS activities. VAS3947 attenuated ROS formation in aortas of spontaneously hypertensive rats (SHRs), where NOS or XOD inhibitors were without effect. CONCLUSIONS AND IMPLICATIONS Our data suggest that triazolo pyrimidines such as VAS3947 are specific NADPH oxidase inhibitors, while DPI and apocynin can no longer be recommended. Based on the effects of VAS3947, NADPH oxidases appear to be a major source of ROS in aortas of SHRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes Nox enzymes but also, for example, complex I of the ETC [63,250,251], iNOS [400,401] and XO [394,399] as well as calcium transporters [402].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [394]
In the citing paper
“However, due to its chemistry, it unselectively inhibits all flavin-containing enzymes of the cell [393,394,399].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [394]
In the citing paper
“VAS2870 was the first published inhibitor that resulted from a systematic screening effort for selective NADPH oxidase inhibitors by Tegtmeier and colleagues [394].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [394]
In the citing paper
“Thus, ROS originating from NOX4 activation may be important in activating microglia in response to neuronal damage via stimulation of p38 MAPK and JNK.”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [157]
In the citing paper
“Whilst the ROS generated here are believed to originate from NOX4 expression, the specificity of apocynin for NOX4 has been questioned [157].”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish
Niethammer, P., Grabher, C., Look, A. T., & Mitchison, T. J. (2009) · Nature · doi:10.1038/nature08119 · Cited by 1,541
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,026
BABIOR, B. M., Lambeth, J. D., & Nauseef, W. M. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2642 · Cited by 911
Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant
Heumüller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H. H. H. W., Busse, R., Schröder, K., & Brandes, R. P. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100214 · Cited by 735
Self-citationKobayashi, M., Ohura, I., Kawakita, K., Yokota, N., Fujiwara, M., Shimamoto, K., Doke, N., & Yoshioka, H. (2007) · The Plant Cell · doi:10.1105/tpc.106.048884 · Cited by 694
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
Cited by
Sorted by citations
Cellular death, reactive oxygen species (ROS) and diabetic complications
Volpe, C. M. O., Villar-Delfino, P. H., dos Anjos, P. M. F., & Nogueira‐Machado, J. A. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0135-z · Cited by 1,214
Simpson, D. S. A., & Oliver, P. L. (2020) · Antioxidants · doi:10.3390/antiox9080743 · Cited by 1,044
“Whilst the ROS generated here are believed to originate from NOX4 expression, the specificity of apocynin for NOX4 has been questioned [157].”
BackgroundCombating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Narasaraju, T., Yang, E., Samy, R. P., Ng, H. H., Poh, W. P., Liew, A.-A., Phoon, M. C., van Rooijen, N., & Chow, V. T. K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.013 · Cited by 918
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. M. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 819
Gasdermin D plays a vital role in the generation of neutrophil extracellular traps
Sollberger, G., Choidas, A., Burn, G. L., Habenberger, P., Lucrezia, R. D., Kordes, S., Menninger, S., Eickhoff, J., Nußbaumer, P., Klebl, B., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar6689 · Cited by 779
Kalogeris, T. J., Bao, Y., & Korthuis, R. J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.05.006 · Cited by 738
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Vincent, A. M., Callaghan, B. C., Smith, A. L., & Feldman, E. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.137 · Cited by 586
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 551
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
Self-citationLove, N. R., Chen, Y., Ishibashi, S., Kritsiligkou, P., Lea, R., Koh, Y. W. H., Gallop, J. L., Dorey, K., & Amaya, E. (2013) · Nature Cell Biology · doi:10.1038/ncb2659 · Cited by 488
NADPH Oxidases in Vascular Pathology
Konior, A., Schramm‐Luc, A., Cześnikiewicz‐Guzik, M., & Guzik, T. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 464
NADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.132159 · Cited by 386
Self-citationThe NOX toolbox: validating the role of NADPH oxidases in physiology and disease
Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Scheurer, P., Rob Hermans, J. J., Schiffers, P., Ho, H., Wingler, K., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1010-9 · Cited by 371
Self-citationJha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352
Self-citationMorry, J., Ngamcherdtrakul, W., & Yantasee, W. (2016) · Redox Biology · doi:10.1016/j.redox.2016.12.011 · Cited by 340
Sakellariou, G. K., Vasilaki, A., Palomero, J., Kayani, A., Zibrik, L., McArdle, A., & Jackson, M. J. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4623 · Cited by 276
Heat stress induces ferroptosis-like cell death in plants
Distéfano, A. M., Martin, M. V., Córdoba, J. P., Bellido, A. M., D’Ippólito, S., Colman, S. L., Soto, D., Roldán, J. A., Bartoli, C. G., Zabaleta, E. J., et al. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201605110 · Cited by 268
Kröller‐Schön, S., Steven, S., Kossmann, S., Scholz, A., Daub, S., Oelze, M. W., Xia, N., Hausding, M., Mikhed, Y., Zinßius, E., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4953 · Cited by 249
Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension
Li, Q., Youn, J.-Y., & Cai, H. “. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000587 · Cited by 244
The influence of reactive oxygen species on cell cycle progression in mammalian cells
Verbon, E. H., Post, J. A., & Boonstra, J. (2012) · Gene · doi:10.1016/j.gene.2012.08.038 · Cited by 237
Targeting NADPH oxidases in vascular pharmacology
Schramm‐Luc, A., Matusik, P. T., Osmenda, G., & Guzik, T. J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.012 · Cited by 233
Rauf, A., Khalil, A. A., Awadallah, S. M., Khan, S. A., Abu‐Izneid, T., Kamran, M., Hemeg, H. A., Mubarak, M. S., Khalid, A., & Wilairatana, P. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3784 · Cited by 220
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors
Cipriano, A., Viviano, M., Feoli, A., Milite, C., Sarno, G., Castellano, S., & Sbardella, G. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00770 · Cited by 208
Mikhed, Y., Görlach, A., Knaus, U. G., & Daiber, A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.05.008 · Cited by 189
Lassig, R., Gutermuth, T., Bey, T., Konrad, K. R., & Romeis, T. (2014) · The Plant Journal · doi:10.1111/tpj.12452 · Cited by 178
NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury
Kleikers, P. W. M., Wingler, K., Hermans, J. J. R., Diebold, I., Altenhöfer, S., Radermacher, K. A., Janssen, B. J., Görlach, A., & Schmidt, H. H. H. W. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0963-3 · Cited by 173
Self-citationMamenko, M., Zaika, O., Ilatovskaya, D. V., Staruschenko, A., & Pochynyuk, O. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298919 · Cited by 144
Amatore, D., Sgarbanti, R., Aquilano, K., Baldelli, S., Limongi, D., Civitelli, L., Nencioni, L., Garaci, E., Ciriolo, M. R., & Palamara, A. T. (2014) · Cellular Microbiology · doi:10.1111/cmi.12343 · Cited by 150
Neuroprotection After Stroke by Targeting NOX4 As a Source of Oxidative Stress
Radermacher, K. A., Wingler, K., Langhauser, F., Altenhöfer, S., Kleikers, P. W. M., Hermans, J. J. R., de Angelis, M. H., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4797 · Cited by 147
Self-citationEndoplasmic Reticulum Stress Regulates the Innate Immunity Critical Transcription Factor IRF3
Liu, Y.-P., Zeng, L., Tian, A., Bomkamp, A., Rivera, D., Gutman, D. M., Barber, G. N., Olson, J. K., & Smith, J. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102737 · Cited by 153
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 147
LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis
Ding, Z., Liu, S., Wang, X., Dai, Y., Khaidakov, M., Deng, X., Fan, Y., Xiang, D., & Mehta, J. L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu114 · Cited by 145
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications
Casas, A. I., Dao, V. T.-V., Daiber, A., Maghzal, G. J., Di Lisa, F., Kaludercic, N., Leach, S., Cuadrado, A., Jaquet, V., Seredenina, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6433 · Cited by 136
Self-citationNADPH oxidases as therapeutic targets in ischemic stroke
Kahles, T., & Brandes, R. P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1011-8 · Cited by 138
Natural Compounds as Modulators of NADPH Oxidases
Maraldi, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/271602 · Cited by 133
Pirotte, N., Stevens, A., Fraguas, S., Plusquin, M., Roten, A. V., Belleghem, F. V., Paesen, R., Ameloot, M. M., Cebrià, F., Artois, T., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/392476 · Cited by 124
NOX5: from basic biology to signaling and disease
Bedard, K., Jaquet, V., & Krause, K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.023 · Cited by 126
Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies
Sedeek, M. H., Montezano, A. C. I., Hébert, R., Gray, S. P., Marco, E. D., Jha, J. C., Cooper, M. E., Jandeleit-Dahm, K. A. M., Schiffrin, E. L., Wilkinson‐Berka, J. L., et al. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9387-2 · Cited by 120
Pharmacological Applications of Antioxidants: Lights and Shadows
Saso, L., & Firuzi, O. (2014) · Current Drug Targets · doi:10.2174/1389450115666141024113925 · Cited by 119
Kim, E. Y., Anderson, M., & Dryer, S. E. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00423.2011 · Cited by 116
Zhu, M., Zhou, M., Shabala, L., & Shabala, S. N. (2016) · Plant Cell & Environment · doi:10.1111/pce.12727 · Cited by 115
Nox1, 2, 4, 5: Counting out oxidative stress
Wingler, K., Hermans, J., Schiffers, P., Moens, A., Paul, M., & Schmidt, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01249.x · Cited by 113
Self-citationRole of NADPH Oxidase-Mediated Reactive Oxygen Species in Podocyte Injury
Chen, S., Meng, X., & Zhang, C. (2013) · BioMed Research International · doi:10.1155/2013/839761 · Cited by 112
NADPH oxidases: redox regulation of cell homeostasis and disease
Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 114
NADPH oxidases: Current aspects and tools
Schröder, K. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101512 · Cited by 110
NADPH Oxidases as Regulators of Tumor Angiogenesis: Current and Emerging Concepts
Coso, S., Harrison, I., Harrison, C. B., Vinh, A., Sobey, C. G., Drummond, G. R., Williams, E. D., & Selemidis, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4489 · Cited by 101
The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side
Togliatto, G., Lombardo, G., & Brizzi, M. F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091988 · Cited by 99
NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS
Cifuentes-Pagano, E., Csányi, G., & Pagano, P. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1009-2 · Cited by 94
New Insight into the Role of Reactive Oxygen Species (ROS) in Cellular Signal-Transduction Processes
Russell, E. G., & Cotter, T. G. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.07.004 · Cited by 95
C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia
Kapur, R., Heitink‐Pollé, K. M. J., Porcelijn, L., Bentlage, A. E. H., Bruin, M. C. A., Visser, R., Roos, D., Schasfoort, R. B. M., de Haas, M., van der Schoot, C. E., et al. (2014) · Blood · doi:10.1182/blood-2014-05-579110 · Cited by 94
NOXious signaling in pain processing
Kallenborn-Gerhardt, W., Schröder, K., Geißlinger, G., & Schmidtko, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.001 · Cited by 93
Riyapa, D., Buddhisa, S., Korbsrisate, S., Cuccui, J., Wren, B. W., Stevens, M. P., Ato, M., & Lertmemongkolchai, G. (2012) · Infection and Immunity · doi:10.1128/iai.00806-12 · Cited by 95
Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?
Rubattu, S., Mennuni, S., Testa, M., Mennuni, M., Pierelli, G., Pagliaro, B., Gabriele, E., Coluccia, R., Autore, C., & Volpe, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141123011 · Cited by 89
The NADPH Oxidase Family and Its Inhibitors
Chocry, M., & Leloup, L. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7915 · Cited by 91
Reactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 93
Long-term exposure to a hypomagnetic field attenuates adult hippocampal neurogenesis and cognition
Zhang, B., Wang, L., Zhan, A., Wang, M., Tian, L., Guo, W., & Pan, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-21468-x · Cited by 86
Zehendner, C. M., Librizzi, L., Hedrich, J., Bauer, N., Angamo, E. A., de Curtis, M., & Luhmann, H. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082823 · Cited by 93
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
Small-Molecule Inhibitors of Reactive Oxygen Species Production
Sassetti, E., Clausen, M. H., & Laraia, L. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01914 · Cited by 85
Oxidative stress–mediated neuroinflammation in Alzheimer’s disease
Firdous, S. M., Khan, S. A., & Maity, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03188-3 · Cited by 90
Kim, E. Y., Anderson, M., Wilson, C., Hagmann, H., Benzing, T. R., & Dryer, S. E. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00191.2013 · Cited by 80
Microvascular NADPH oxidase in health and disease
Li, Y., & Pagano, P. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.049 · Cited by 79
How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin
Vockel, M., & Vestweber, D. (2013) · Blood · doi:10.1182/blood-2013-04-499228 · Cited by 79
Targeting NOX enzymes in the central nervous system: therapeutic opportunities
Sorce, S., Krause, K., & Jaquet, V. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1014-5 · Cited by 79
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U. G., & Schmidt, H. H. H. W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.038 · Cited by 81
Self-citationPhytoglobins Improve Hypoxic Root Growth by Alleviating Apical Meristem Cell Death
Mira, M. M., Hill, R. D., & Stasolla, C. (2016) · PLANT PHYSIOLOGY · doi:10.1104/pp.16.01150 · Cited by 77
Sun, Q.-A., Hess, D. T., Wang, B., Miyagi, M., & Stamler, J. S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.046 · Cited by 76
Inhibiting the Activity of NADPH Oxidase in Cancer
Konaté, M. M., Antony, S., & Doroshow, J. H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8046 · Cited by 81
Feillet‐Coudray, C., Fouret, G., Elle, R. E., Rieusset, J., Bonafos, B., Chabi, B., Crouzier, D., Žarković, K., Žarković, N., Ramos, J., et al. (2014) · Free Radical Research · doi:10.3109/10715762.2014.945079 · Cited by 76
Octavia, Y., Rocca, H. B., & Moens, A. L. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.482 · Cited by 75
Essential role of ERK activation in neurite outgrowth induced by α-lipoic acid
Wang, X., Wang, Z.-Y., Yao, Y., Li, J., Zhang, X., Li, C., Cheng, Y., Ding, G., Liu, L., & Ding, Z. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.027 · Cited by 77
Redox‐based therapeutics in neurodegenerative disease
McBean, G. J., López, M. G., & Wallner, F. K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13551 · Cited by 77
Gatto, G. J. J., Ao, Z., Kearse, M. G., Zhou, M., Morales, C. R., Daniels, E., Bradley, B. T., Goserud, M. T., Goodman, K. B., Douglas, S. A., et al. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.636360 · Cited by 76
Munnamalai, V., Weaver, C. J., Weisheit, C. E., Venkatraman, P., Agim, Z. S., Quinn, M. T., & Suter, D. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12734 · Cited by 70
“Apocynin is still widely used as NADPH oxidase inhibitor; however, there is now evidence that it may act as antioxidant and require the presence of myeloperoxidase to function as a NADPH oxidase inhibitor (Heumuller et al. 2008; Jaquet et al. 2009; Wind et al. 2010).”
BackgroundMethodNADPH oxidase inhibitors: a patent review
Kim, J., Neupane, G. P., Lee, E. S., Jeong, B., Park, B. C., & Thapa, P. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.584870 · Cited by 70
Gong, H., Gao, X., Feng, S., Siddiqui, M. R., Garcia, A. N., Bonini, M. G., Komarova, Y. A., Vogel, S. M., Mehta, D., & Malik, A. B. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131190 · Cited by 69
NADPH Oxidase as a Therapeutic Target for Oxalate Induced Injury in Kidneys
Joshi, S. K., Peck, A. B., & Khan, S. R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/462361 · Cited by 70
Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation
Zielonka, J., Zielonka, M., VerPlank, L., Cheng, G., Hardy, M., Ouari, O., Ayhan, M. M., Podsiadły, R., Sikora, A., Lambeth, J. D., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702787 · Cited by 67
Carbone, F., Teixeira, P. C., Braunersreuther, V., Mach, F., Vuilleumier, N., & Montecucco, F. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5778 · Cited by 68
Benlloch, M., Obrador, E., Vallés, S. L., Rodríguez, M. L., Sirerol, J. A., Alcácer, J., Pellicer, J. A., Palmer, R. S., Cerdá, C., Sáez, G. T., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6437 · Cited by 68
VAS2870 is a pan-NADPH oxidase inhibitor
Wingler, K., Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1107-1 · Cited by 70
Self-citationLo, J., Patel, V. B., Wang, Z., Levasseur, J. L., Kaufman, S., Penninger, J. M., & Oudit, G. Y. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.067165 · Cited by 65
Current status of NADPH oxidase research in cardiovascular pharmacology
Álvarez, E., Rodiño-Janeiro, Paradela-Dobarro, Castiñeiras-Landeira, Raposeiras‐Roubín, S., & González‐Juanatey, J. R. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33053 · Cited by 64
Bosco, E. E., Kumar, S., Marchioni, F., Biesiada, J., Kordos, M., Szczur, K., Meller, J., Seibel, W. L., Mizrahi, A., Pick, E., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.017 · Cited by 62
Daiber, A., Oelze, M. W., Steven, S., Kröller‐Schön, S., & Münzel, T. F. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.001 · Cited by 65
ROS production as a common mechanism of ENaC regulation by EGF, insulin, and IGF-1
Ilatovskaya, D. V., Pavlov, T. S., Levchenko, V., & Staruschenko, A. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00231.2012 · Cited by 61
Siddiqui, T. A., Lively, S. S., & Schlichter, L. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0531-9 · Cited by 67
Molecular insights of NADPH oxidases and its pathological consequences
Waghela, B. N., Vaidya, F. U., Agrawal, Y., Santra, M. K., Mishra, V., & Pathak, C. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3589 · Cited by 60
Derochette, S., Franck, T. J., Mouithys-Mickalad, A. A., Ceusters, J. D., Deby-Dupont, G. P., Lejeune, J., Neven, P., & Serteyn, D. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.09.011 · Cited by 57
Hemoglobin Control of Cell Survival/Death Decision Regulates in Vitro Plant Embryogenesis
Huang, S., Hill, R. D., Wally, O. S. D., Dionisio, G., Ayele, B. T., Jami, S. K., & Stasolla, C. (2014) · PLANT PHYSIOLOGY · doi:10.1104/pp.114.239335 · Cited by 58
Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4
Fazeli, G., Stopper, H., Schinzel, R., Ni, C., Jo, H., & Schupp, N. (2012) · Mutagenesis · doi:10.1093/mutage/ges033 · Cited by 55
Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151029112013 · Cited by 55
Huang, W.-Y., Lin, S., Chen, H.-Y., Chen, Y., Chen, T.-Y., Hsu, K., & Wu, H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1186-5 · Cited by 54
Moe, K. T., Khairunnisa, K., Yin, N. O., Chin-Dusting, J. P. F., Wong, P. E. H., & Wong, M. C. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0345-0 · Cited by 54
Ismail, H. M., Scapozza, L., Rüegg, U. T., & Dorchies, O. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110708 · Cited by 52
NADPH Oxidases as Therapeutic Targets in Chronic Myelogenous Leukemia
Sánchez-Sánchez, B., Gutiérrez-Herrero, S., López-Ruano, G., Prieto-Bermejo, R., Romo-González, M., Llanillo, M., Pandiella, A., Guerrero, C., Miguel, J. F. S., Sanchez-Guijo, F. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3044 · Cited by 51
Metadata
- Authors
- Wind, S., Beuerlein, K., Eucker, T., Müller, H., Scheurer, P., Armitage, M., Ho, H., Schmidt, H., & Wingler, K.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Vasopharm (Germany) (DE)
- Florey Institute of Neuroscience and Mental Health (AU)
- ORCID
- Wind, S
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-06-17
- Volume
- 161
- Issue
- 4
- Pages
- 885-898
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2970907
- OpenAlex
- W1736337862
- Cited by
- 241
- References
- 50
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 13 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 16 · 2016: 23 · 2015: 23 · 2014: 28 · 2013: 29 · 2012: 31
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Deutsche Forschungsgemeinschaft (SFB-547)
- Bayerische Forschungsstiftung
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- NADPH oxidase inhibitors, reactive oxygen species, oxidative stress, diphenyleneiodonium, apocynin, AEBSF, xanthine oxidase inhibition, eNOS inhibition, spontaneously hypertensive rats, aorta
- MeSH terms
- Acetophenones, Animals, Aorta, Cell Line, Enzyme Inhibitors, Humans, Onium Compounds, Pyrimidines, Rats, Inbred SHR, Rats, Inbred WKY, Sulfones, Triazoles, Reactive Oxygen Species, Oxidative Stress, HL-60 Cells, Caco-2 Cells, NADPH Oxidases, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review